154 related articles for article (PubMed ID: 6276063)
1. Role of the kallikrein-kinin system in the renal effects of angiotensin-converting enzyme inhibition in anaesthetized dogs.
Clappison BH; Anderson WP; Johnston CI
Clin Exp Pharmacol Physiol; 1981; 8(5):509-13. PubMed ID: 6276063
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
3. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
Clappison BH; Anderson WP; Johnston CI
Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
[TBL] [Abstract][Full Text] [Related]
4. Role of prostaglandins in the renal response to angiotensin-converting enzyme inhibition and renal artery occlusion.
van Leeuwen BH; Anderson WP; Johnston CI
J Cardiovasc Pharmacol; 1983; 5(5):883-8. PubMed ID: 6195481
[TBL] [Abstract][Full Text] [Related]
5. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
McCaa RE
Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
[TBL] [Abstract][Full Text] [Related]
6. Roles of endogenous angiotensin II or kinin in the mechanism of altered renal vascular responsiveness to angiotensin II following acute blood volume expansion in the dog.
Akabane S; Kojima S; Ito K; Kawamura M
Jpn J Pharmacol; 1984 Oct; 36(2):235-40. PubMed ID: 6392654
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
Filep J; Rigter B; Földes-Filep E
J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
[TBL] [Abstract][Full Text] [Related]
8. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
[TBL] [Abstract][Full Text] [Related]
9. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
10. Role of the kinin-kallikrein system in the vasodilator action of an angiotensin converting enzyme inhibitor (captopril) on the systemic resistance and capacitance vessels of dogs.
Ito H; Sahashi T; Hirose I; Nagata K; Wada H; Takai K; Hirakawa S
Jpn Circ J; 1991 Sep; 55(9):857-64. PubMed ID: 1942492
[TBL] [Abstract][Full Text] [Related]
11. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
Shimamoto K; Matsuki T; Iimura O
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
[TBL] [Abstract][Full Text] [Related]
13. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
Nasjletti A; Colina-Chourio J; McGiff JC
Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
[TBL] [Abstract][Full Text] [Related]
14. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
Iimura O; Shimamoto K
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
[No Abstract] [Full Text] [Related]
16. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D
Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
[TBL] [Abstract][Full Text] [Related]
18. Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
Tanaka S; Shimamoto K; Ando T; Nakahashi Y; Ura N; Hosoda S; Ishida H; Yamaji I; Yokoyama T; Masuda A
Clin Exp Hypertens A; 1987; 9(2-3):605-9. PubMed ID: 3038424
[TBL] [Abstract][Full Text] [Related]
19. Effects of a kinin antagonist on renal function in rats.
Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
[TBL] [Abstract][Full Text] [Related]
20. Role of kinins and angiotensin II in the renal hemodynamic response to captopril.
Mattson DL; Roman RJ
Am J Physiol; 1991 May; 260(5 Pt 2):F670-9. PubMed ID: 2035654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
